CD10 as a novel marker of therapeutic resistance and cancer stem cells in head and neck squamous cell carcinoma

BACKGROUND: Cancer stem cells (CSCs) are responsible for treatment failure. However, their identification and roles in resistance are not well established in head and neck squamous cell carcinoma (HNSCC). METHODS: Three HNSCC cell lines (FaDu, Detroit562 and BICR6) were treated with cisplatin or rad...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukusumi, T, Ishii, H, Konno, M, Yasui, T, Nakahara, S, Takenaka, Y, Yamamoto, Y, Nishikawa, S, Kano, Y, Ogawa, H, Hasegawa, S, Hamabe, A, Haraguchi, N, Doki, Y, Mori, M, Inohara, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119971/
https://www.ncbi.nlm.nih.gov/pubmed/24874475
http://dx.doi.org/10.1038/bjc.2014.289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119971/
https://www.ncbi.nlm.nih.gov/pubmed/24874475
http://dx.doi.org/10.1038/bjc.2014.289

Ejemplares similares